Viking Therapeutics Stock Options

VKTX Stock  USD 49.21  1.36  2.84%   

Viking Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Viking Total Stockholder Equity

Total Stockholder Equity

365.84 Million

At this time, Viking Therapeutics' Total Stockholder Equity is fairly stable compared to the past year.

Viking Therapeutics Corporate Management

CPA CPAChief OfficerProfile
Michael MorneauVice AdministrationProfile
Marianne ManciniChief OfficerProfile
Geoffrey BarkerSenior DevelopmentProfile

Additional Tools for Viking Stock Analysis

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.